JP2024510334A5 - - Google Patents
Info
- Publication number
- JP2024510334A5 JP2024510334A5 JP2023557756A JP2023557756A JP2024510334A5 JP 2024510334 A5 JP2024510334 A5 JP 2024510334A5 JP 2023557756 A JP2023557756 A JP 2023557756A JP 2023557756 A JP2023557756 A JP 2023557756A JP 2024510334 A5 JP2024510334 A5 JP 2024510334A5
- Authority
- JP
- Japan
- Prior art keywords
- neisseria
- antigen
- chimeric molecule
- binding
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163161399P | 2021-03-15 | 2021-03-15 | |
| US63/161,399 | 2021-03-15 | ||
| PCT/AU2022/050213 WO2022192937A1 (en) | 2021-03-15 | 2022-03-14 | Pathogen moieties and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510334A JP2024510334A (ja) | 2024-03-06 |
| JP2024510334A5 true JP2024510334A5 (https=) | 2025-03-25 |
Family
ID=83321844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557756A Pending JP2024510334A (ja) | 2021-03-15 | 2022-03-14 | 病原体部分及びその用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240156970A1 (https=) |
| EP (1) | EP4308155A4 (https=) |
| JP (1) | JP2024510334A (https=) |
| KR (1) | KR20240004299A (https=) |
| CN (1) | CN117377484A (https=) |
| AU (1) | AU2022241364A1 (https=) |
| BR (1) | BR112023018748A2 (https=) |
| CA (1) | CA3212271A1 (https=) |
| MX (1) | MX2023010850A (https=) |
| WO (1) | WO2022192937A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264970A1 (en) * | 1998-03-10 | 1999-09-10 | American Cyanamid Company | Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| EP2573100A1 (en) * | 2011-09-23 | 2013-03-27 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis |
| PL404229A1 (pl) * | 2013-06-06 | 2014-12-08 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością | Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie |
| WO2016007891A1 (en) * | 2014-07-10 | 2016-01-14 | University Of Iowa Research Foundation | Vaccine for nontypeable haemophilus influenzae |
-
2022
- 2022-03-14 AU AU2022241364A patent/AU2022241364A1/en active Pending
- 2022-03-14 WO PCT/AU2022/050213 patent/WO2022192937A1/en not_active Ceased
- 2022-03-14 BR BR112023018748A patent/BR112023018748A2/pt unknown
- 2022-03-14 US US18/550,659 patent/US20240156970A1/en active Pending
- 2022-03-14 CN CN202280035329.4A patent/CN117377484A/zh active Pending
- 2022-03-14 JP JP2023557756A patent/JP2024510334A/ja active Pending
- 2022-03-14 MX MX2023010850A patent/MX2023010850A/es unknown
- 2022-03-14 CA CA3212271A patent/CA3212271A1/en active Pending
- 2022-03-14 KR KR1020237034995A patent/KR20240004299A/ko active Pending
- 2022-03-14 EP EP22770065.5A patent/EP4308155A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2352765C (en) | Hapten-carrier conjugates for treating and preventing nicotine addiction | |
| JP4656728B2 (ja) | ブドウ球菌抗原及びワクチン | |
| FI104539B (fi) | Menetelmä muunnellun Neisseria meningitidis ryhmä B polysakkaridin tai muunnellun E. coli K1 kotelomaisen polysakkaridin valmistamiseksi | |
| JP2019089845A (ja) | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ感染に対する多糖類ワクチン | |
| JP2001519402A (ja) | 腸球菌抗原およびワクチン | |
| AU2006309274B2 (en) | Method of protecting against staphylococcal infection | |
| AU2007349275B2 (en) | Method of protecting against staphylococcal infection | |
| AU5000199A (en) | Polysaccharide vaccine for staphylococcal infections | |
| JP5237259B2 (ja) | 過剰産生黄色ブドウ球菌株の５型および８型莢膜多糖 | |
| JP2024510334A5 (https=) | ||
| Jennings | N-Propionylated group B meningococcal polysaccharide glycoconjugate vaccine against group B meningococcal meningitis | |
| AU2010320031B2 (en) | (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine | |
| US8124743B2 (en) | Purification of a bivalently active antibody using a non-chromatographic method | |
| JP2008517876A (ja) | 髄膜炎菌由来の誘導体化多糖類−タンパク質の多価コンジュゲートおよびワクチン | |
| Cox et al. | Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera | |
| Devi et al. | Binding diversity of monoclonal antibodies to α (2→ 8) polysialic acid conjugated to outer membrane vesicle via adipic acid dihydrazide | |
| JP2025509292A5 (https=) |